Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 783

Results For "RAT"

8414 News Found

QMS Medical partners with ZEISS for screening diabetic retinopathy
Medical Device | September 27, 2021

QMS Medical partners with ZEISS for screening diabetic retinopathy

Remote screening of diabetic retinopathy can help in early detection, even before there are any noticeable vision changes


Fujifilm to verify effectiveness of AI technology in health screening services
Digitisation | September 27, 2021

Fujifilm to verify effectiveness of AI technology in health screening services

This project will be conducted at the “NURA,” a health screening centre that Fujifilm opened in India in February this year


U.S. FDA approves Repatha for paediatric patients aged 10 years and older
Drug Approval | September 27, 2021

U.S. FDA approves Repatha for paediatric patients aged 10 years and older

The FDA also approved Repatha as an adjunct to other LDL-C lowering therapies for the treatment of homozygous familial hypercholesterolemia (HoFH) for younger pediatric patients


Cadila Healthcare signs agreement with Shilpa Medicare for production of ZyCoV-D
News | September 26, 2021

Cadila Healthcare signs agreement with Shilpa Medicare for production of ZyCoV-D

ZyCoV-D is the first DNA plasmid vaccine in the world for human use, developed indigenously by the company against the Covid-19 virus


U.S. FDA completes inspection of Biocon Biologics, Malaysia with six observations
Biotech | September 26, 2021

U.S. FDA completes inspection of Biocon Biologics, Malaysia with six observations

The company does not expect the outcome of this inspection to impact its plans


SAB Biotherapeutics’ SAB-185 moves to Phase 3 trial for Covid-19 treatment
Biotech | September 26, 2021

SAB Biotherapeutics’ SAB-185 moves to Phase 3 trial for Covid-19 treatment

Advancement to Phase 3 is a major milestone for SAB’s unique DiversitAb immunotherapy platform that produces fully human polyclonal antibodies without human donors


MedleyMed enters the U.S. market with a suite of digital health solutions
Digitisation | September 26, 2021

MedleyMed enters the U.S. market with a suite of digital health solutions

The company plans to launch its exclusive e-pharmacy and telemedicine services in India by December 2021


Zydus Cadila receives final approval for Apremilast
Drug Approval | September 24, 2021

Zydus Cadila receives final approval for Apremilast

Zydus' Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy


Lancet publishes NanoFlu vaccine Phase 3 trial results
News | September 24, 2021

Lancet publishes NanoFlu vaccine Phase 3 trial results

The pivotal Phase 3 trial achieved all primary endpoints, demonstrating non-inferiority to a leading U.S.-licensed quadrivalent influenza vaccine


Amaris Clinicals clears U.S. FDA audit
News | September 24, 2021

Amaris Clinicals clears U.S. FDA audit

The company is the Clinical Research Organisation of Caplin Point Laboratories